Last reviewed · How we verify

NCT03743948: DIAFEXOME

NIPD of CFTC by WGA Coupled to Mini-exome Sequencing

Status unknown NA Last updated 27 September 2019
What this trial tests

NA trial testing Non invasive prenatal diagnosis in Monogenic Diseases in 18 participants. Status unknown.

Timeline
19 December 2018
Primary endpoint
27 August 2019
30 December 2019

Quick facts

Lead sponsorUniversity Hospital, Montpellier
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment18
Start date19 December 2018
Primary completion27 August 2019
Estimated completion30 December 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Montpellier

Who can join

18 and older, any sex, with Monogenic Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purprose of this study is to develop a single test based on circulating fetal trophoblastic cells (CFTC) analysis from maternal blood, searching for the familial mutation for a wide range of monogenic diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non invasive prenatal diagnosis

Trials testing the same drug.

Other recruiting trials for Monogenic Diseases

Currently open trials in the same condition.

Other University Hospital, Montpellier trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03743948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing